Home
About
Overview
Sharing Data
ORCID
Help
History (62)
HIV Seroprevalence
Bernard-Soulier Syndrome
Peritoneovenous Shunt
Araliaceae
NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma.
See All 62 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma.
NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma. J Immunother Cancer. 2024 Aug 30; 12(8).
View in:
PubMed
subject areas
Animals
Brain Neoplasms
Cell Line, Tumor
Female
Glioblastoma
Humans
Immunotherapy
Killer Cells, Natural
Mice
NK Cell Lectin-Like Receptor Subfamily C
Tumor Microenvironment
authors with profiles
Derek A. Wainwright